Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP +)-induced neurotoxicity in MES23.5 dopaminergic cells

International Journal of Toxicology

Volumn 29, Issue 6, 2010, Pages 625-633

  Du, Tingting ^a   Li, Lu ^a   Song, Ning ^a   Xie, Junxia ^a   Jiang, Hong ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

apoptosis; MPP+; Parkinson's disease; rosmarinic acid

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CASPASE 3; DOPAMINE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROSMARINIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RESPIRATORY CHAIN;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIOXIDANTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; CELL SURVIVAL; CINNAMATES; DEPSIDES; DOPAMINE; ELECTRON TRANSPORT COMPLEX I; GENE EXPRESSION REGULATION; HERBICIDES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; RATS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 78650864787     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581810383705     Document Type: Article

References (37)

1. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci. 2003 ; 991: 1-14.
2. Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature. 2006 ; 443 (7113). 796-802.
3. Jenner P., Olanow CW The pathogenesis of cell death in Parkinson's disease. Neurology. 2006 ; 66 (10 suppl 4). S24 - S36.
4. Jiang H., Luan Z., Wang J., Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int. 2006 ; 49 (6). 605-609.
5. Xie J., Jiang H., Chen W., Qian Z. Dopamine release rather than content in the caudate putamen is associated with behavioral changes in the iron rat model of Parkinson's disease. Exp Neurol. 2003 ; 182 (2). 483-489.
6. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003 ; 39 (6). 889-909.
7. Hunot S., Hirsch EC Neuroinflammatory processes in Parkinson's disease. Ann Neurol. 2003 ; 53 (suppl 3). S49 - S58 ; discussion S58 - S60.
8. Barnham KJ, Masters CL, Bush AI Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004 ; 3 (3). 205-214.
9. Markey SP, Johannessen JN, Chiueh CC, Burns RS, Herkenham MA Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature. 1984 ; 311 (5985). 464-467.
10. Petersen M., Simmonds MS Rosmarinic acid. Phytochemistry. 2003 ;62(2): 121-125.
11. Zheng W., Wang SY Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem. 2001 ; 49 (11). 5165-5170.
12. Lin YL, Chang YY, Kuo YH, Shiao MS Anti-lipid-peroxidative principles from Tournefortia sarmentosa. J Nat Prod. 2002 ; 65 (5). 745-747.
13. Gao LP, Wei HL, Zhao HS, Xiao SY, Zheng RL Antiapoptotic and antioxidant effects of rosmarinic acid in astrocytes. Pharmazie. 2005 ; 60 (1). 62-65.
14. Wei T., Zhao X., Hou J., et al. The antioxidant ESeroS-GS inhibits NO production and prevents oxidative stress in astrocytes. Biochem Pharmacol. 2003 ; 66 (1). 83-91.
15. Kim DS, Kim HR, Woo ER, Hong ST, Chae HJ, Chae SW. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem Pharmacol. 2005 ; 70 (7). 1066-1078.
16. Iuvone T., De Filippis D., Esposito G., D'Amico A., Izzo AA The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther. 2006 ; 317 (3). 1143-1149.
17. Ren P., Jiang H., Li R., et al. Rosmarinic acid inhibits 6-OHDAinduced neurotoxicity by anti-oxidation in MES23.5 cells J Mol Neurosci. 2009 ; 39 (1-2). 220-225.
18. Crawford GD Jr, Le WD, Smith RG, Xie WJ, Stefani E., Appel SH A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J Neurosci. 1992 ; 12 (9). 3392-3398.
19. Shi L., Song N., Jiang H., Wang J., Ma Z., Xie J. Potassium channels are involved in zinc-induced apoptosis in MES23.5 cells J Neurosci Res. 2009 ; 87 (2). 514-521.
20. Xu HM, Jiang H., Wang J., Luo B., Xie JX Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells. Neurochem Int. 2008 ; 52 (6). 1044-1051.
21. Zhang S., Wang J., Song N., Xie J., Jiang H. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. Neurobiol Aging. 2009 ; 30 (9). 1466-1476.
22. Zhu HJ, Liu GQ Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism. Life Sci. 2004 ; 75 (11). 1313-1322.
23. Sanelli T., Ge W., Leystra-Lantz C., Strong MJ Calcium mediated excitotoxicity in neurofilament aggregate-bearing neurons in vitro is NMDA receptor dependant. J Neurol Sci. 2007 ; 256 (1-2). 39-51.
24. Ramsay RR, Krueger MJ, Youngster SK, Gluck MR, Casida JE, Singer TP Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J Neurochem. 1991 ; 56 (4). 1184-1190.
25. Chan PH Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia. Neurochem Res. 2004 ; 29 (11). 1943-1949.
26. Oltvai ZN, Milliman CL, Korsmeyer SJ Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993 ; 74 (4). 609-619.
27. Soobrattee MA, Neergheen VS, Luximon-Ramma A., Aruoma OI, Bahorun T. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res. 2005 ; 579 (1-2). 200-213.
28. Swarup V., Ghosh J., Ghosh S., Saxena A., Basu A. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother. 2007 ; 51 (9). 3367-3370.
29. Sanbongi C., Takano H., Osakabe N., et al. Rosmarinic acid inhibits lung injury induced by diesel exhaust particles. Free Radic Biol Med. 2003 ; 34 (8). 1060-1069.
30. Singer TP, Ramsay RR Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett. 1990 ; 274 (1-2). 1-8.
31. Storch A., Kaftan A., Burkhardt K., Schwarz J. 1-Methyl-6,7-dihydroxy-1, 2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 2000 ; 855 (1). 67-75.
32. Simpkins JW, Dykens JA Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev. 2008 ; 57 (2). 421-430.
33. Dong J., Song N., Xie J., Jiang H. Ghrelin antagonized 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. J Mol Neurosci. 2009 ; 37 (2). 182-189.
34. Budd RC Death receptors couple to both cell proliferation and apoptosis. J Clin Invest. 2002 ; 109 (4). 437-441.
35. Reed JC Double identity for proteins of the Bcl-2 family. Nature. 1997 ; 387 (6635). 773-776.
36. Lotharius J., O'Malley KL The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem. 2000 ; 275 (49). 38581-38588.
37. Takeda H., Tsuji M., Miyamoto J., Matsumiya T. Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress. Psychopharmacology (Berl). 2002 ; 164 (2). 233-235.